Search hospitals > Iowa > Des Moines
Iowa Methodist Medical Center
Claim this profileDes Moines, Iowa 50309
Global Leader in Parotid Gland Cancer
Global Leader in Relapse
Conducts research for Cervical Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Cancer
347 reported clinical trials
4 medical researchers
Summary
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Parotid Gland Cancer, Relapse, Cervical Adenocarcinoma, Breast Cancer, Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 496 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Relapse
Global LeaderStage IV
Stage III
Stage I
Top PIs
Joshua LukenbillMedical Oncology and Hematology Associates-Des Moines2 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
140 reported clinical trials
215 drugs studied
Samantha L. MalloryBlank Children's Hospital8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
56 reported clinical trials
107 drugs studied
Robert J. BehrensIowa Methodist Medical Center5 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
43 reported clinical trials
97 drugs studied
Joshua LuckenbillIowa Methodist Medical Center4 years of reported clinical research
Studies Head and Neck Cancers
1 reported clinical trial
1 drug studied
Clinical Trials running at Iowa Methodist Medical Center
Breast Cancer
Lung Cancer
Parotid Gland Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Breast cancer
Esophageal Adenocarcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Iowa Methodist Medical Center?
Where is Iowa Methodist Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Iowa Methodist Medical Center accept?
What awards or recognition has Iowa Methodist Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.